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There is abundant evidence that H2O2 can act as an endothelium-derived hyperpolarizing factor in the
resistance vasculature. However, whilst scavenging H2O2 can abolish endothelial dependent hyperpo-
larization (EDH) and the associated vascular relaxation in some arteries, EDH-dependent vasorelaxation
can often be mimicked only by using relatively high concentrations of H2O2. We have examined the role
of H2O2 in EDH-dependent vasodilatation by simultaneously measuring vascular diameter and changes
in endothelial cell (EC) [Ca2þ]i during the application of H2O2 or carbachol, which triggers EDH. Car-
bachol (10 mM) induced dilatation of phenylephrine-preconstricted rat cremaster arterioles was largely
(73%) preserved in the presence of indomethacin (3 mM) and L-NAME (300 mM). This residual NO- and
prostacyclin-independent dilatation was reduced by 89% upon addition of apamin (0.5 mM) and TRAM-34
(10 mM), and by 74% when an extracellular ROS scavenging mixture of SOD and catalase (S&C;
100 U ml1 each) was present. S&C also reduced the carbachol-induced EC [Ca2þ]i increase by 74%.
When applied in Ca2þ-free external medium, carbachol caused a transient increase in EC [Ca2þ]i. This
was reduced by catalase, and was enhanced when 1 mM H2O2 was present in the bath. H2O2 -induced
dilatation, which occurred only at concentrations Z100 mM, was reduced by a blocking antibody to
TRPM2, which had no effect on carbachol-induced responses. Similarly, iberotoxin and Rp-8bromo cGMP
reduced the vasodilatation induced by H2O2, but not by carbachol. Inhibiting PLC, PLA2 or CYP450 2C9
each greatly reduced the carbachol-induced increase in EC [Ca2þ]i and vasodilatation, but adding 10 mM
H2O2 during PLA2 or CYP450 2C9 inhibition completely restored both responses. The nature of the ef-
fective ROS species was investigated by using Fe2þ chelators to block the formation of ∙OH. A cell per-
meant chelator was able to inhibit EC Ca2þ store release, but cell impermeant chelators reduced both the
vasodilatation and EC Ca2þ inﬂux, implying that ∙OH is required for these responses. The results indicate
that rather than mediating EDH by acting directly on smooth muscle, H2O2 promotes EDH by acting
within EC to enhance Ca2þ release.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).r Inc. This is an open access article
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Endothelium-dependent hyperpolarization (EDH) plays an im-
portant role in the vasodilatation of small arteries and arterioles
induced by diverse stimuli including locally released factors, blood
ﬂow, and low pH [1]. EDH was initially viewed as resulting from
the release of a diffusible endothelial factor, termed EDHF [2], but
is now also thought to involve the transmission of endothelial cell
hyperpolarization to the underlying vascular smooth muscle cells
(VSMCs) via myoendothelial gap junctions [3]; the relative im-
portance of each mechanism is thought to vary between different
arteries/arterioles and also depends on the degree of pre-existing
vascular excitation [4]. In either case, calcium-activated potassium
channels KCa2.3 and KCa3.1 (SKCa and IKCa respectively) have been
shown to play a signiﬁcant part in the EDH response (EDHR).
Pomposiello et al. [5] suggested that H2O2 has a role to play inunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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domethacin-resistant vasodilatation and hyperpolarization eli-
cited by acetylcholine in mouse small mesenteric arteries was
attenuated by catalase and associated with increased endothelial
ROS production [6]. Further evidence that H2O2 acts as an EDHF
was also reported for dog coronary resistance arteries [7,8] and
human small mesenteric [9] and coronary arteries [10]. Liu et al.
[11] showed that an endothelium-denuded segment of human
coronary artery dilated when it was perfused by the efﬂuent from
an upstream endothelium-intact artery subjected to increased
shear stress, and that this dilatation was attenuated if an H2O2-
scavenging column was interposed between the donor and re-
cipient arteries. The possibility that H2O2 acts as an EDHF is also
consistent with observations by other groups that application of
exogenous H2O2 opens VSMC BKCa channels [12], hyperpolarizes
VSMCs [13] and relaxes a variety of vascular preparations [10,14–
16]. The evidence for H2O2 as the primary contributor to the EDHR
evoked by bradykinin is also compelling for cerebral arterioles, in
which it appears that cyclooxygenase-dependent production of
H2O2 causes vasodilation by acting on BKCa channels [16,17]. Most
convincingly, Eaton et al. [18] showed that a mouse with knocked-
in redox-insensitive protein kinase G were hypertensive and had
mesenteric vessels that were less sensitive to applied H2O2.
However, one concern with many of the studies in which the effect
of exogenous H2O2 was examined is that the EC50 for H2O2 – in-
duced vasodilatation of endothelium-denuded arteries was above
10 μM e.g. [10,14,16] Notably, Liu et al. [11] reported that whereas
the vasodilating efﬂuent they collected from endothelium-intact
perfused human coronary arteries contained 0.6 μM H2O2, vaso-
dilatation of endothelium-denuded arteries by exogenous H2O2
was negligible at a concentration of 10 μM.
Intriguingly, although H2O2 dilated endothelium-intact human
submucosal intestinal microvessels, it caused constriction follow-
ing endothelial denudation, a ﬁnding which led to the suggestion
that H2O2 promotes the release of a separate EDHF instead of itself
acting as an EDHF [15]. It was subsequently shown by Grifﬁth and
co-workers that the application of 100 μM H2O2, or the oxidizing
agent thimerosal, to rabbit aortic valve endothelial cells (EC) en-
hanced intracellular Ca2þ release evoked by the SERCA inhibitor
cyclopiazonic acid (CPA). Moreover, CPA-induced vasodilatation of
rabbit ileac arteries was attenuated by application of catalase. They
proposed that H2O2 could potentiate EDH-dependent vasodilata-
tion by increasing IP3 - dependent Ca2þ release [19]. Soon after-
wards this group demonstrated that applying H2O2 concentrations
of 10–30 μM also potentiated the EDH-associated vasodilation
caused by acetylcholine in rabbit ileac arteries [20].
These studies suggest strongly that H2O2 acts to enhance rather
than mediate the EDHR, and pose a number of important ques-
tions which are currently unanswered. As the ability of H2O2 to
facilitate the EDHR has not been compared to its direct vasodilator
effects in any single preparation, it remains unknown which of
these effects are likely to be of predominant importance during
the EDHR. Also, the pathways leading to H2O2 production within
EC which would facilitate increases in EC [Ca2þ]i during the EDH
response have not been deﬁned. In addition, it is not clear whether
physiological stimuli which have been shown to increase ROS
production in EC lead to increases in the EDHR as would be pre-
dicted by this mechanism.
We have investigated these issues in arterioles in the intact rat
cremaster circulation, as this preparation exhibits robust, sustained
and consistent dilatations to both carbachol and H2O2, and permits
endothelial Ca2þ concentration changes to be measured simulta-
neously. We characterized the effects of anti-oxidants and blockers
of potential ROS-producing pathways on increases in EC [Ca2þ]i and
the associated NO- and PGI2-independent vasodilation evoked by
the muscarinic receptor agonist carbachol. In addition, we carriedout a comparison of the effects of carbachol and exogenously ap-
plied H2O2 in order to determine whether H2O2 might be acting as
an EDHF. We also assessed whether EDH and ROS contribute to the
vasodilatation induced by the inﬂammatory mediator cytokine
IL-1β. Our results show that under basal conditions, endogenous
ROS production involving CYP92C, phospholipase A2 and hydroxyl
radical greatly facilitates EC Ca2þ release and EDH-associated va-
sodilation. A brief pre-incubation with IL-1β further enhances the
responses to carbachol. Although H2O2 also dilated these arterioles
directly, it only did so at high concentrations, and via mechanisms
which differ markedly from those evoked by carbachol.2. Methods
This study conforms with the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85–23, revised 1996) and is in ac-
cordance with UK Home Ofﬁce regulations (Animals Scientiﬁc
Procedures) Act, 1986.
4–6 week old male Wistar rats (Charles River, UK) weighing 80–
100 g were killed by exposure to an increasing concentration of
CO2 followed by cervical dislocation. A midline incision was made
along the abdomen and the skin and muscle layer were retracted
to expose the underlying organs. The inferior vena cava was tied
off above the bifurcation into the common iliac veins and below
that an incision was made to allow blood to drain from the lower
extremities. A 0.61 mm ﬁne bore polythene cannula was inserted
down to the bifurcation into the common iliac arteries via the
abdominal aorta and secured with thread. The left common iliac
and the right femoral and internal iliac arteries were ligated to
ensure that perfusion was only to the right external iliac artery
supplying the cremaster artery and the cremaster muscle. This was
then perfused through the cannula with a stabilizing solution
(10 Mg2þ , 110 NaCl, 8 KCl, 10 HEPES, 1 CaCl2þ all mM) containing
heparin (30 U/ml) with isoproterenol 10 mM buffered to pH
7.070.05 for 10 min to remove all blood.
The cremaster muscle was prepared by a midline incision along
the scrotum to expose the right testes. Skin and connective tissue
were carefully removed from the underlying cremaster muscle,
which was then cut longitudinally along the anterior surface from
the apex to the inguinal canal while keeping the vascular supply
and drainage at the base intact. The testis was separated from the
cremaster muscle and was pulled through the inguinal canal so as
not to obstruct the preparation. The muscle was spread out ﬂat
onto a clear Sylgard disc using forceps and secured using micro-
histology pins, and the cardioplegic solution perfusing the circu-
lation was then replaced for the duration of the experiment with
PSS containing 0.1% albumin delivered by a gravity controlled re-
servoir. The preparation was moved to the stage of a Leitz In-
travital microscope equipped with Orthoplan optics, and was su-
perfused with PSS at 37 °C at a ﬂow rate of 2.5 ml/min. PSS con-
tained the Naþ channel blocker lidocaine (20 mg l1) to block
neural activity and keep the cremaster muscle from contracting.
Following a 30 min equilibration period an appropriate 2nd
order arteriole (diameter 50–100 mm) was constricted by super-
fusion with 30 mM phenylephrine (PE) in combination with
300 mM N(G)-nitro-L-arginine methyl (L-NAME) and 3 mM in-
domethacin to inhibit NO and PGI2 mediated vasodilatation.
Constriction was maintained for 20 min to ensure its stability, and
the muscarinic receptor agonist carbachol (10 mM) was then added
for 2 min to the superfusate to elicit vasodilation. Arterioles were
used for experiments only if a vasodilatation of 450% (measured
as described below) was observed.
During the experiments PE, L-NAME and indomethacin were
present throughout. Drugs used to characterize the EDHR were
Fig. 1. Properties of the carbachol-induced EDHR in rat cremaster micro-
vasculature. (A) Representative experiment illustrating the constricting effect of
applying phenylephrine (30 mM) and the subsequent sustained dilating action of
carbachol (10 mM). (B) Paired experiments in which the dilatation induced by car-
bachol was reduced by co-applying L-NAME (300 mM) with indomethacin (3 mM),
and subsequent apamin (0.5 mM) with Tram-34 (10 mM) or (C) a ROS scavenging
mixture of superoxide dismutase and catalase (100 U/ml each). Analysis of variance
followed by Tukey's multiple comparison test ***po0.001, **po0.01.
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application of carbachol. In experiments examining the effect of IL-
1β, the preparation was superfused for 15 min with PSS containing
the cytokine at a concentration of 100 pM. IL-1β was then washed
out brieﬂy and carbachol was applied.
2.1. Diameter measurements and EC [Ca2þ]i measurements
Arterioles were visualized with a x40 water-immersion objec-
tive lens (allowing diameter measurements to be taken to an ac-
curacy of 1 mm) and were perfused for 1 h at room temperature
with PSS containing 10 μM Fura-PE 3 AM, 1% DMSO, 0.02%
pluronic acid and 1% albumin in order to selectively load the en-
dothelium with furaPE3. The preparation was then perfused with
PSS and the superfusate temperature was raised to 37 °C. Follow-
ing a 15 min equilibration and washout period, arterioles were
illuminated alternately at 360 and 380 nm at 1 Hz using a ﬁlter
wheel (Cairn Research Ltd, UK) and images were recorded at
4530 nm using an Intensiﬁed ISIS camera (Photonic Sciences, UK).
Images were analyzed using ImageHopper (Samsara Research:
Dorking, Surrey, UK) software. Diameter was measured using the
inner margin of the 380 nm signal. A semi-quantitative calculation
of the endothelial Ca2þ concentration (hereafter termed EC
[Ca2þ]i) was made by subtracting the average background (ad-
jacent to the arterioles) signal from the image, normalizing the
signals from the vessel during the 360 and 380 nm excitation in-
tervals, and calculating the 360/380 ratio at each pixel. PE had no
effect on the 360/380 ratio, which indicates that FuraPE3 was
conﬁned to the endothelium. Furthermore, carbachol and TRAM-
34 co-applied with apamin produced changes in the 360/380 ratio
that would be expected from selective FuraPE3 endothelium
loading.
2.2. Drugs and solutions
PSS contained (in mM) 124 NaCl, 5 KCl, 22 NaHCO3, 5 glucose,
2 MgSO4, 0.125 NaH2PO4, 2 CaCl2, and was gassed with 5% CO2 -
balance air to maintain the pH at 7.40. St. Thomas’ cardioplegic
(stabilizing) solution contained (in mM) 110 NaCl, 7.9 KCl 34
MgCl2, 1 CaCl2, 11 HEPES, 0.01 isoprenaline and 0.01 ascorbic acid
as an antioxidant. Drugs were made up freshly each day or made
from stock solutions stored at 20 °C with ﬁnal concentrations
made up in PSS. All drugs were purchased from Sigma Aldrich UK,
other than: TRPM2 antibody (Cambridge Bioscience), arachidonyl
triﬂuoromethyl ketone (AACOCF3: Merck Chemicals), heparin
(AAH Hospital Services), TRAM-34 (Tocris Bioscience) and lido-
caine (Braun Medical). CP94 (1,2-diethyl-3-hyroxypyridin-4-one)
and CP85 (Na-1-ethylsulfoxide-2-methyl-3-hyroxypyridin-4-one)
were kind gifts from Professor R.C. Hider, King's College London.
2.3. Presentation of data and statistical analysis
Endothelial cell [Ca2þ]i is represented as the peak % increase in
the Fura-PE3 360/380 ratio from the baseline. Vasodilatation is
represented as the maximum % reversal of PE-induced constric-
tion. Carbachol responses were recorded under control conditions
and then again following an intervention (e.g. application of an
inhibitor), so that each arteriole acted as its own control and re-
sults could be analyzed using a two-tailed paired t-test. It was
possible to do so because the responses evoked by carbachol were
stable when repeated (rise in Fura-PE3 360/380 ratio and vasodi-
lation of 20.572.4% and 75.373.5%, respectively, during ﬁrst
application of carbachol; rise in Fura-PE3 360/380 ratio and va-
sodilation of 22.172.6% and 72.573.2%, respectively during sec-
ond response to carbachol applied 15 min later, n¼21, ns). Bar
charts represent mean7S.E.M values.3. Results
3.1. Role of ROS in EDH-associated carbachol-induced vasodilation of
rat cremaster arterioles
PE (30 mM) application to cremaster resulted in a sustained con-
striction (3673%, n¼5), and subsequent carbachol (10 mM) applica-
tion resulted in a well-maintained vasodilatation, amounting to a
72.672.4% reversal of the constriction (n¼55). Fig. 1A shows an
example of this, and Figs. 1B and 1C illustrate the results of 4 paired
experiments in which the vasodilatation of arterioles and their ac-
companying venules was measured. The vasodilatation was reduced
somewhat in the presence of L-NAME (300 mM) and indomethacin
(3 mM) (Fig. 1B). Interestingly, this was less in the venules than the
arterioles (arteriolar vasodilatation reduction 3071.3%, venular re-
duction 1971.7%; po0.001 t-test, 8 paired vessels). Addition of
apamin (0.5 mM) with Tram-34 (10 mM) to block endothelial SKCa
(KCa2.3) and IKCa (KCa3.2) channels respectively, resulted in a much
greater reduction: a further 6273.3% in arterioles and 7071.3% in
venules (po0.05 t-test, 4 paired vessels). When a free radical
scavenging mixture of superoxide dismutase (SOD) and catalase (S&C;
both 100 U/ml) was used instead of Tram-34 and apamin (Fig. 1C)
there was a similar reduction in carbachol-induced vasodilatation
(arterioles 4975.3% and venules 6275.2% 4 paired vessels, ns).
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panied by a sustained increase in EC [Ca2þ]i which was not af-
fected by the presence of L-NAME and indomethacin (24.575.4 vs
24.174.6% increase, n¼4, ns). All experiments described hereafter
were carried out in the presence of L-NAME and indomethacin in
order to allow the EDH-associated vasodilatation to be recorded in
isolation.
As shown in Fig. 2, both the rise in EC [Ca2þ]i and the vasodi-
latation induced by carbachol were greatly diminished in the
presence of S&C. Fig. 2A illustrates images of the 360/380 ﬂuor-
escence emission ratio in a Fura PE3 loaded cremaster arteriole in
the presence of PE (upper left), and after 10 μM carbachol was
applied (upper right). The arteriole was subsequently washed with
PSS, superfused with PE in the presence of S&C (lower left), and
again exposed to carbachol (lower right). The effect of S&C on the
carbachol-induced increase in EC [Ca2þ]i was sustained, as shown
in Fig. 2B. Fig. 2C shows that in six paired vessels that S&C appli-
cation reduced the carbachol-induced vasodilatation (left) and
increase in EC [Ca2þ]i (right) on each occasion.
Carbachol stimulates muscarinic M1 and M2 receptors which will
result in activating phospholipase C and phospholipase A2 respec-
tively. Inhibiting PLC with 3 μM U73122 resulted in much reduced
vasodilatation and Ca2þ responses (to 11.671.1% and 13.871.8%,
respectively), whereas the inactive U73122 analogue U73343 (3 μM)
had no effect on either response (Fig. 3A). This suggests that store
release of Ca2þ is a key requirement for the EDH response. Similarly
PLA2 inhibition by 3 μMAACOCF3 also reduced the vasodilatation and
Ca2þ responses (Fig. 3B), but to a lesser extent. The arachidonic acid
released by PLA2 can interact with a number of enzymes to generate
reactive oxygen species (ROS), notably cyclooxygenases, lipox-
ygenases, xanthine oxidase, and cytochrome P450 isoforms. We used
a number of inhibitors to investigate possible sources, namely allo-
purinol (xanthine oxidase), nordihydroguaiaretic acid (lipoxygenase),Fig. 2. Carbachol-induced EDHF response is ROS dependent. (A) Example of the effect of S
in an arteriole, and (B) the time course of the carbachol-induced rise in the 360/380 nm
endothelial [Ca2þ]i responses to carbachol (n¼6) paired t-test, ***po0.001, **po0.01)and sulfaphenazole (cytochrome P450), while indomethacin was
always present to block cyclooxygenase. Of these only sulfaphenazole,
a selective cytochrome P450 2C9 inhibitor [21] reduced the responses
to carbachol (Fig. 3C). The less speciﬁc inhibitors 2-(2-propynyloxy)-
benzenehexanoic acid (PPOH) and 17-octadecynoc acid (ODYA) were
equally effective (Supplementary Fig. 1). These effects were not due to
a reduction in the production of EETs, since neither the EETs an-
tagonist 4, 15-epoxyeicosa-5(Z)-enoic acid (EEZE) nor the soluble
epoxide hydrolase (sEH) blocker 12-(3-adamantan-1-yl-ureido)do-
decanoic acid (AUDA) had any effect on the carbachol responses
(Supplementary Fig. 2B). It is interesting to note that the reduction in
vasodilatation and the Ca2þ response with AACOCF3 and sulfaphe-
nazole was signiﬁcantly less than with PLC inhibition (AACOCF3 va-
sodilatation 25.676.9% and EC [Ca2þ]i 24.974.1%; sulfaphenazole
vasodilatation 30.174.4% and EC [Ca2þ]i 37.273.7%) (Anova: EC
[Ca2þ]i Po0.005; vasodilatation Po0.05).
3.2. H2O2 assists release of Ca
2þ from intracellular stores
Carbachol-induced release of intracellular Ca2þ by the en-
dothelium was recorded in arterioles perfused and superfused with
Ca2þ free PSS containing 0.2 mM EGTA in order to prevent Ca2þ
inﬂux. Under these conditions carbachol caused a transient increase
in EC [Ca2þ]i, which was signiﬁcantly attenuated by S&C (Fig. 4A and
B). Further experiments revealed that the increase in EC [Ca2þ]i was
similarly reduced by catalase alone, but was unaffected by SOD
(Fig. 4B). Since reducing H2O2 levels suppressed the carbachol-in-
duced increase in EC [Ca2þ]i and the associated vasodilation, it
might be predicted that increasing H2O2 levels should correspond-
ingly facilitate the response to carbachol. As depicted in Fig. 4C,
application of 1 μM exogenous H2O2 signiﬁcantly increased the
transient carbachol-induced rise in EC [Ca2þ]i in Ca2þ-free PSS. The
role of cytochrome P450 2C9 in assisting Ca2þ release was&C (both 100 U/ml) on the carbachol-mediated rise in EC [Ca2þ]i and vasodilatation
ratio and its attenuation by S&C. (C) S&C reduces the vasodilatation and (D) the
.
Fig. 3. Paths by which carbachol induces EDHF response. (A) The PLC inhibitor
U73122, but not the structurally similar U73343 (both 3 mM), very much reduced
the [Ca2þ]i (from 22.373.2%) and the vasodilatation (from 75.372.7 to
10.471.9%) responses to carbachol (10 mM). (B) The PLA2 inhibitor AACOCF3 (3 mM)
and (C) the cytochrome P450 2C9 inhibitor sulfaphenazole (10 mM) also reduced
the [Ca2þ]i and vasodilatation responses. 5 vessels in 5 animals for each data set;
paired t-tests *** po0.001. The reduction with U73122 was greater than with ei-
ther AACOCF3 or sulfaphenazole (see text).
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this response.
The results depicted in Figs. 3 and 4 are consistent with the
concept that arachidonic acid released by PLA2 is metabolized by
CYP2C9 to produce ROS, which then potentiate carbachol-induced
Ca2þ release. To further test this idea we added H2O2 (10 mM, a
concentration that produced no vasodilatation on its own (see
next section and Fig. 6A) to preparations where either PLA2 or
CYP2C9 were blocked with AACOOCF3 or sulphaphenazole, re-
spectively. In both cases H2O2 fully restored vasodilatation and
Ca2þ responses (see Fig. 5A & B).
3.3. Properties of the response to H2O2 applied exogenously on its
own
Application of H2O2 to PE-preconstricted arterioles caused a
steeply concentration-dependent vasodilatation, with an apparent
threshold at 30 μM and maximum at 100 μM H2O2 (Fig. 6A).
When evaluated in a larger number of arteries, vasodilatation at
100 μM H2O2 was similar to but slightly smaller than that induced
by 10 μM carbachol (73.771.4% vs 80.871.4%, n¼22, po0.05),and was accompanied by a rise in EC [Ca2þ]i which was also
somewhat smaller than that caused by carbachol (22.671.4% vs
26.071.4%, n¼22, p o0.05).
The possibility that the exogenously applied H2O2 resulted in
opening the TRPM2 channel was tested by using a blocking anti-
body that had been shown to block H2O2-induced Ca2þ inﬂux into
cultured endothelial cells [22]. It is interesting to note that the
EC50 for activation of this channel by H2O2 (60 mM), is consistent
with the dose-response relationship we found (Fig. 6A). Applica-
tion of the TRPM2 antibody reduced both the H2O2-induced rise in
EC [Ca2þ]i and vasodilatation, but left these responses to carbachol
unaffected (Fig. 6B).
Although both 100 μM H2O2 and carbachol caused roughly
equivalent effects on EC [Ca2þ]i and vascular diameter, they ap-
parently did so through different mechanisms. As shown in
Figs. 6C and 6D, the vasodilatation elicited by H2O2 was strongly
suppressed by the protein kinase G blocker Rp-8-Br-cyclic GMP
(100 μM) and the BKCa channel inhibitor IBTx, (100 nM), and was
to a smaller extent also sensitive to the combination of apamin
(500 nM) and TRAM-34 (10 mM). Conversely, Rp 8Br-cyclic GMP
and IBTx had no effect on the H2O2-induced rise in EC [Ca2þ]i,
which was strongly supressed by the TRPM2 antibody and TRAM-
34þapamin. Inhibiting PKG and the BKCa channel, however, had
no effect on the carbachol-mediated responses (Figs. 6E and 6F).
TRAM-34 and apamin reduced vasodilatation mediated by H2O2
(3772.8%), to an extent which was which was signiﬁcantly less
than that observed for the response to carbachol (8272.8%;
Po0.001).
In additional experiments we found that CP94, which inhibited
carbachol induced vasodilation (see below), had no affect on di-
latation to H2O2 (78.072.5% in H2O2 vs 77.072.1% in H2O2 with
CP94, n¼5, ns). H2O2-induced vasodilation was also unaffected by
AACOCF3 (69.871.8% in H2O2 vs 68.771.8% in H2O2þAACOCF3,
n¼5, ns).
3.4. The nature of the ROS involved in carbachol-mediated effects
Desferrioxamine and the hydroxypyridinones CP94 and CP85
are selective iron chelators, but differ in that CP94 is cell perme-
able while the other two are not [49]. As shown in Fig. 7A, CP94
(100 μM) signiﬁcantly reduced the transient carbachol-induced
rise in EC [Ca2þ]i in Ca2þ free PSS, while neither desferrioxamine
nor CP85 (100 μM) had any effect on this response. This supports
the view that ∙OH, rather than H2O2 itself, is the radical re-
sponsible for Ca2þ release from stores.
In the presence of extracellular Ca2þ , all three iron chelators
inhibited the carbachol-induced rise in endothelial [Ca2þ]i
(Fig. 7B) and reduced the accompanying vasodilation (Fig. 7C).
Notably, none of these substances had any effect on the PE induced
contraction (not shown).
3.5. IL-1β causes ROS-dependent vasodilatation and elevation of EC
[Ca2þ]i
We have previously shown that a brief application of a low
concentration of interleukin-1β (30 pM for 10 min) results in en-
dothelial ROS generation via NADPH oxidase [23], and that this is
prevented by co-application with a low concentration of apocynin
(1 mM; [24]). As shown in Fig. 8, a 15 min pre-incubation of the
preparation with IL-1β (30 pM), followed by a subsequent brief
wash to remove the cytokine, resulted in increased EC [Ca2þ]i and
vasodilatation responses that were much reduced by scavenging
ROS. Furthermore, this potentiating effect was abolished when
apocynin (1 μM) was co-applied and washed off with IL-1β.
NADPH oxidase assembly requires phosphorylation of p47phox by
protein kinase C [25], and when the broad spectrum PKC inhibitor
Fig. 4. Role of ROS on endothelial Ca2þ release using Ca2þ-free Krebs buffer. (A) Example of the effect of S&C (both 100 U/ml) on the carbachol-induced rise in EC [Ca2þ]i.
(B) Average effect of SOD and catalase applied in combination or independently on the peak carbachol-induced transient rise in EC [Ca2þ]i. (C) Effect of 1 mM H2O2 and (D) of
sulfaphenazole (10 mM) on the carbachol induced increase in EC [Ca2þ]i. (n¼5 for B-D, paired t-test **po0.01, ***po0.001).
Fig. 5. Reversal of the effects of ROS-generating enzyme inhibition by H2O2. 10 μM H2O2, which alone had no effect on vessel diameter, was applied to arterioles where
(A) AACOCF3 (3 mM) or (B) sulphaphenazole (10 mM) had reduced the carbachol induced vasodilatation (left) and rise in EC [Ca2þ]i (right). In both cases, H2O2 fully reversed
the effects of the inhibitors. (5 vessels from 5 animals; paired t-test *** po0.001).
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also abolished. Neither apocynin nor Ro31-8220 affected the re-
sponse to carbachol in the absence of IL-1β (Supplementary Fig. 3).4. Discussion
The key ﬁnding of this study is that whilst the EDHR triggered by
carbachol is largely ROS-dependent, it does not involve an effect onVSMCs of H2O2 released by the endothelium. Instead, the results
demonstrate that ROS generated by endothelial cytochrome P450
2C9 make a crucial contribution to the EDHR triggered by mus-
carinic receptor stimulation in rat cremaster arterioles. They do this
by acting on the endothelium to potentiate Ca2þ release from in-
tracellular stores and enhancing Ca2þ entry across the plasma
membrane rather than by acting directly as an EDHF. There have
been previous indications that this is an important mechanism:
thus catalase suppresses cyclopiazonic acid (CPA) induced Ca2þ
Fig. 6. Effects of exogenous hydrogen peroxide. (A) Concentration dependency of H2O2 induced vasodilation with 300 mM L-NAME and 10 mM indomethacin present (n¼4).
(B) Pre-incubation with TRPM2 antibody (5 mg ml1) reduced the vasodilatation and Ca2þ responses to exogenous H2O2, but not to carbachol. (C) H2O2 caused vasodilatation
that was inhibited by Rp-8bromo cGMP (100 mM), IBTx (100 nM), but these had no effect on EC [Ca2þ]i. (D) The combination of TRAM34 (10 mM) and apamin (0.5 mM)
reduced the vasodilatation and Ca2þ responses. In contrast, neither Rp-8bromo cGMP nor IBTx had any inﬂuence on the carbachol, responses (E & F). n¼5–9 vessels, each
from separate animals.
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dent, acetylcholine-induced vasodilatation of rabbit iliac arteries.
Furthermore, raising the H2O2 concentration facilitates acetylcho-
line and CPA induced vasodilatation [19,20]. CPA induced Ca2þ re-
lease was also shown to be potentiated by the IP3R sensitising agent
thimerosal, which implies that H2O2 may be exerting a similar
sensitising effect, as described for the IP3R in human aortic en-
dothelial cells [26]. Based on these and related ﬁndings, the late
Tudor Grifﬁth and colleagues proposed that H2O2 was acting to
promote the EDH response by facilitating IP3R-mediated endothelial
Ca2þ release and thereby raising [Ca2þ]I [19].
4.1. Phospholipase C, Phospholipase A2 and CYP450 2C9
Carbachol activates both M1 and M2 receptors, which are linked
to phospholipase C and phospholipase A2 respectively. The presentﬁndings indicate that both are required for the full EDHR. We
showed that blocking PLC with U73122 inhibits increases in both
endothelial [Ca2þ]i and vasodilatation (see Fig. 3A), which is
consistent with the ﬁnding that many agonists evoke vasodilata-
tion and [Ca2þ]i increases that are dependent on endothelial PLC
activation [27]. Our results are consistent with those of Fukao et al.
who showed that PLC is crucial for the EDHR in rat mesenteric
arteries, implying that IP3R-mediated Ca2þ release is pivotal for
both events [28].
We have also shown that a pathway involving both cPLA2 and
CYP2C9 is the source for ROS in the carbachol-induced EDHR in
these arterioles. Our results (Fig. 3B), demonstrate that the cPLA2
inhibitor AACOCF3 suppressed the carbachol-induced EDHR. A role
for cPLA2 in EDH has previously been demonstrated in some [29–
31] but not all arteries [32]. Although this could reﬂect a role for
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by cPLA2, it may also depend upon ROS produced the same
pathway. This possibility was investigated in porcine coronary
arteries, but it was found that this did not apply to the EDHR
triggered by bradykinin [5]. In contrast, increases in endothelial
permeability evoked by bradykinin in cerebral venular capillaries
were found to depend on ROS generated when arachidonic acid
produced by cPLA2 is metabolised by cyclooxygenase and lipox-
ygenase [33].
CYP450 has been thought to be involved in the EDH response
by virtue of its production of EETs, which were initially proposed
to act via opening BKCa channels in vascular smooth muscle cells
e.g. [34,35]. More recently however, EETs generated by CYP450 2C9
were shown to act within endothelial cells by increasing [Ca2þ]i by
recruiting TRP channels to the plasmalemma [21,36].
On the other hand, CYP450 enzymes are also a source of ROS
[37], and furthermore, basal ROS production by endothelial cells is
dependent on the CYP450 2C9 isoform, as shown by using anti-
sense oligonucleotides [35] and sulfaphenazole [37], both of which
suppress EDH. Nevertheless, the possibility that CYP450 2C9 might
promote EDH via ROS generation [38], as indicated by the results
depicted in Fig. 3C, seems not to have been previously considered.
Sulfaphenazole strongly suppressed carbachol-induced Ca2þ re-
lease, as well as the rise in EC [Ca2þ]i and the associated vasodi-
latation in normal Ca2þ solution, and neither the EETs antagonist
EEZE nor AUDA had any effect on the carbachol responses (Sup-
plementary Fig. 2B). Moreover, although in accordance with pre-
vious reports e.g. [39] we observed that BKCa channel blockade
with IBTx inhibited the vasodilatation caused by application of
exogenous 11, 12 EET, IBTx had no effect on the carbachol-induced
vasodilatation (Supplementary Fig. 2A).
4.2. Exogenously applied H2O2
Whereas the experiments with anti-oxidants and blockers of
endothelial ROS-producing pathways indicate that H2O2 acts by
potentiating the carbachol-induced EC [Ca2þ] increase, they do
not exclude an additional direct effect of H2O2 on arteriolar vas-
cular smooth muscle during EDH. We therefore carried out a
systematic comparison of the properties of the vasodilator re-
sponses to H2O2 and carbachol-induced EDH. The dose response
relationship between H2O2 and vasodilatation (Fig. 6A) is con-
sistent with most others that do not show signiﬁcant vasodilata-
tion below 50 mM e.g. [6,11]. The vasodilatation caused by H2O2
was strongly attenuated by Rp-8Br-cGMP and IBTx (see Fig. 6C).
Neither of these blockers had any effect on the H2O2 induced rise
in endothelial [Ca2þ]i (see Fig. 6D), consistent with the concept
that H2O2 evokes vasodilatation principally via vascular smooth
muscle cells by causing direct oxidation-induced stimulation of G
kinase [18], this leading to cGMP-mediated opening of BKCa
channels [40]. In contrast, responses to carbachol were insensitive
to these agents, implying that any release of H2O2 on its own by
the endotheliumwas too small to activate this pathway. It appears,
however, that the rise in endothelial [Ca2þ]i triggered by 100 μM
H2O2 also makes a signiﬁcant contribution to the vasodilatation,
since the combination of TRAM-34 and apamin reduced vasodi-
lation to H2O2. Moreover, a TRPM2 antibody previously shown to
block H2O2-induced rises in [Ca2þ]i associated with activation of
these channels in cultured EC greatly suppressed the H2O2-in-
duced rise in EC [Ca2þ]i and reduced the accompanying vasodi-
latation [22]. These results suggest that the endothelium-depen-
dent component of the vasodilatation to 100 μM H2O2 in these
arterioles was largely caused by the opening of EC TRPM2 chan-
nels, leading to a rise in EC [Ca2þ]i and a consequent EDHR. This
would be expected to open endothelial KCa channels, accounting
for the small inhibition of the H2O2 induced rise in endothelial[Ca2þ]i caused by TRAM-34þapamin (Figs. 6D, 6F). The observa-
tion that the TRPM2 antibody had no effect on either the rise in
endothelial [Ca2þ]i or the vasodilatation induced by carbachol
(Fig. 5B) further highlights the difference between the pathways
by which carbachol and H2O2 regulate endothelial [Ca2þ]i.
It has been argued that a relatively high exogenously applied
H2O2 concentration does not accurately reﬂect the true in-
tracellular H2O2 due to the effects of peroxidases and a hypothe-
sized barrier to H2O2 entry across the plasmalemma [41]. On the
other hand, H2O2 has been shown to have a high permeability
coefﬁcient (1.6103 cm s1) across the EC membrane [42].
Furthermore, we found that the application of just 1 mM H2O2
resulted in a signiﬁcant increase in carbachol-induced Ca2þ re-
lease from intracellular stores (see Fig. 4C). Notably, studies have
shown that H2O2 at concentrations r100 μM does not itself cause
EC Ca2þ release in the absence of a co-stimulus. Hu et al. [26]
measured the content of the Ca2þ stores in permeabilized cultured
human aortic endothelial cells (HAEC) using Mag-indo, and found
that this was not affected by 100 μM H2O2, although H2O2 at
concentrations above 3 μM sensitized these cells to IP3-induced
Ca2þ release and 10 μM H2O2 promoted histamine-mediated Ca2þ
release in intact HAEC [43]. Similarly it was found that 100 µM
H2O2 had no effect on EC Ca2þ store content, measured using Mag
ﬂuo-4, in intact rabbit aortic valve endothelium [19].
Similarly, the effects of inhibiting either PLA2 with AACOCF3, or
CYP450 2C9 with sulfaphenazole were completely reversed by
adding H2O2 (10 μM), a concentration which on its own had no
effect (see Figs. 5A and 5B). Thus, it is clear that the suppression of
the carbachol-induced EDHR by sulfaphenazole is best explained
by a decrease in endothelial H2O2 rather than the inhibition of EET
release it causes. This effect would explain the ﬁnding that the
EDH-dependent vasodilatation to acetylcholine in guinea-pig
coronary arteries was antagonised by CYP450 blockers but not
IBTx [39], as well as the observation that sulfaphenazole-induced
attenuation of the EDHR triggered by acetylcholine and bradykinin
in the human forearm microcirculation was prevented by co-ad-
ministration of the anti-oxidant ascorbate [44].
These ﬁndings indicate that ROS produced when CYP 450 2C9
metabolises arachidonic acid generated by cPLA2 are responsible
for an increase in Ca2þ release by the IP3R. There is evidence [45]
that H2O2 is able to sensitize the IP3R to various stimuli in cultured
endothelial cells. This view is supported to a certain extent by our
ﬁnding that inhibiting PLC produced a signiﬁcantly greater re-
duction in the response to carbachol than inhibiting elements of
the ROS generating pathway (see Fig. 3).
4.3. Reactive oxygen species mediated signalling
It is apparent that H2O2 generated from the interaction be-
tween arachidonic acid and CYP 450 2C9 is important for po-
tentiating the release of Ca2þ from stores, since catalase alone,
rather that superoxide dismutase reduces effects of carbachol.
The question of whether the Fenton reaction is required for
H2O2 to have its effects was addressed by using Fe2þ chelators.
The involvement of hydroxyl radical in endothelium-dependent
vasodilation was ﬁrst proposed as a consequence of ﬁnding that
desferrioxamine (DFO) inhibited bradykinin-induced vasodilata-
tion of mouse cerebral arterioles [46]. Few subsequent studies
have addressed this issue, however, and the limited amount of
information available on the effects of iron chelation on the EDH as
such indicates that hydroxyl radical is not involved [10,30].
Nonetheless, in light of reports that DFO attenuated arachidonate-
induced vasodilatation and permeability increases in rat cerebral
arterioles [17,47], and of our observation that blocking cPLA2
suppressed the responses to carbachol in cremaster arterioles, we
examined whether these were also affected by DFO and the iron
Fig. 7. Effects of iron chelation on carbachol responses. Effects of the cell perme-
able CP94 and the cell impermeable desferrioxamine, CP85 (each 100 mM) iron
chelators on carbachol responses. (A) In Ca2þ-free PSS the induced rise in the EC
[Ca2þ]i is reduced only with CP94. (B) When Ca2þ was included in the medium all
the chelators reduced the [Ca2þ]i and the (C) vasodilatation responses. (5 vessels
from 5 animals; paired t test *po0.05, **po0.01).
Fig. 8. Evidence that IL-1β increases the response to carbachol via NADPH oxidase.
IL-1β (30 pM) applied for 15 min. resulted in increased (A) vasodilatation and (B) EC
[Ca2þ]I responses. Co-application with either apocynin (1 mM) or Ro31-8220 (3 mM)
blocked the increases, while a radical scavenging mixture of SOD and catalase
(100 U/ml each) reduced the total responses. (5 vessels from 5 animals; paired t-
tests **po0.01; ***po0.001; IL-1β vs IL-1β þapocynin # unpaired ‘t’ test po0.05.
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little direct radical scavenging ability [48], moreover a variety of
3-hydroxypyridin-4-ones of varying membrane permeability have
been synthesised which allowed us to compare the effects of high
(CP94) and low (CP85) cell-permeability analogues [49].
If hydroxyl radical rather than H2O2 is sensitising the IP3R, it
would be predicted that CP94 and DFO but not CP85 should inhibit
carbachol-induced Ca2þ release, since hydroxyl radical, which
immediately reacts with other molecules in its vicinity as it is
formed, is unlikely to cross the cell membrane [50]. This is what
we observed. Although the enormous reactivity of hydroxyl radical
would appear to prevent it from mediating signal transduction, as
this would require spatially discrete and reversible interactions,there are mechanisms by which this could occur. For example,
hydroxyl anion is largely scavenged by ascorbate to yield dehy-
droascorbate (see [50]), which has been proposed to be trans-
ported into the lumen of the ER where it acts to promote the
oxidation of protein thiols [51]. This might be of particular re-
levance to Ca2þ release. Notably, it was shown that treatment of
aortic EC with H2O2 leads to glutathionylation of the IP3R1 and an
increase in its sensitivity to [Ca2þ] [45], and it was proposed that
this might be due to its interaction with ERp44, an ER-resident
protein which inhibits the IP3R1 by binding to it in a redox-sen-
sitive manner, such that oxidation of cysteine residues on the
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therefore enhances channel opening [52]. We speculate that such
a mechanism could provide a feasible explanation for how the
non-localised production of hydroxyl anion within the cytoplasm
might result in a localised and reversible effect on signal trans-
duction, in this case an increase in Ca2þ release.
Although CP94 profoundly inhibited carbachol-induced en-
dothelial Ca2þ release, the cell impermeant CP85 and DFO had no
effect (Fig. 6A). In the presence of extracellular Ca2þ , however, all
the chelators reduced the response, which indicates that the hy-
droxyl radical formed outside the cell membrane is involved in the
opening of the KCa channels (Figs. 6B and 6C), which is evidence
for H2O2 crossing the plasmalemma. There is evidence that several
ROS-sensitive Ca2þ - permeable channels, including TRPC3, TRPC4
and TRPM2, can contribute to Ca2þ inﬂux in EC during the re-
sponse to muscarinic agonists [27,53]. Of these, to our knowledge
a role for hydroxyl radical as a channel activator has only been
reported for TRPM2, although this was shown to involve an action
on intracellular cysteine residues [54].
4.4. IL-1β and EDH
The ability of IL-1β to promote EDH has not, to our knowledge,
been reported previously, although it has been reported that this
cytokine caused dilatation of new-born pig pial arterioles via a
prostanoid- and cyclic nucleotide-dependent-mechanism [55].
The effects of IL-1β were prevented when it was co-applied with
the NADPH-oxidase assembly inhibitor apocynin and the PKC
blocker Ro31-8220, consistent with previous evidence that Il-1β
activates increases superoxide production and activates NADPH
oxidase in EC [23,56,57]. The effect of IL-1β on the carbachol-in-
duced EDHR in cremaster arterioles demonstrated several parallels
with its effect on the bradykinin-induced permeability increase of
rat pial venules described byWoodﬁn et al. [23] including a similar
rapid induction and a sensitivity to ROS scavenging, apocynin and
PKC blockade, and we speculate that activation of NADPH oxidase
may constitute a widespread mechanism by which IL-1β can
acutely regulate EC [Ca2þ]i in the vascular endothelium, and may
be one of the factors that are involved in septic shock.5. Conclusions
We speculate that arteries/arterioles may fall into three cate-
gories with regard to the involvement of H2O2 in EDH. In one
group, as evidenced by the lack of effect of catalase, H2O2 is
probably not involved in this response [4], although such a role
has not been exhaustively examined for every stimulus which
triggers EDH in these preparations. In another group, which no-
tably includes coronary arteries, H2O2 itself seems to act as an
important EDHF [6,7,10,11]. The reports of Grifﬁth and colleagues
[19,20] pointed to the existence of a third group of arteries in
which H2O2 facilitates EDH, and focussed attention on IP3R-
mediated Ca2þ release in EC as its likely target. Our results now
provide a more detailed picture of how H2O2 acts to promote EDH
in the type of arteriole that falls into this category. We ﬁnd that
very small changes in the EC [H2O2] around the basal level can
strongly modulate the EDHR via an effect on Ca2þ release. The
data demonstrate that EDH triggered by muscarinic receptor ac-
tivation is greatly facilitated by ROS which are produced when
arachidonic acid synthesised by cPLA2 is metabolised by CYP450
2C9. A short pre-treatment with IL-1β is able to further enhance
carbachol-induced EDH. An increase in EC Ca2þ release, which
would be expected to potentiate SOCE, and thereby also facilitate
EC Ca2þ inﬂux, is implicated in these responses. The effects of
CP94 and CP85 indicate that hydroxyl radical plays an importantrole in this facilitation of Ca2þ release, and also demonstrate that
ROS also promote EC Ca2þ inﬂux during EDH.
A limitation of our results is that we could not record changes
in [ROS] in the endothelium of these arterioles, possibly because
these were very small. We were therefore unable to determine
whether muscarinic receptor activation was increasing EC [ROS],
or whether basal ROS levels were sufﬁcient to facilitate Ca2þ re-
lease. PLA2 has, however, been shown to be activated by increases
in EC [Ca2þ]i, e.g. [58] so that it is plausible that PLA2-dependent
ROS production would occur upon the application of carbachol.Author contributions
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